Fig. 7

GM-CSF treatment leads to increased expression of MHC-II and decreased expression of CD206. A Plot of MHC-II versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. B Plot of CD206 versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. C Plot of CD86 versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. D Plot of CD14 versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. E Plot of CD80 versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. F Quantitative analysis of MHCII⁺, CD206⁺, CD86⁺,CD14⁺,and CD80⁺ percentages